B-Cell Lymphoproliferative Disorder: Clinical Trials

3 trials for B-Cell Lymphoproliferative Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Recruiting 2

Follow B-Cell Lymphoproliferative Disorder: new trials by email Literature Review of B-Cell Lymphoproliferative Disorder trials Research Report on B-Cell Lymphoproliferative Disorder

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia
Pacritinib - Waldenström Macroglobulinemia, Lymphoplasmacytic Lymphoma
Phase 2RecruitingShayna Sarosiek, MD302025-11-212025-12-05
Epcoritamab in Previously Treated WM
Epcoritamab - Waldenstrom Macroglobulinemia, B-Cell Lymphoproliferative Disorder
Phase 2RecruitingGottfried von Keudell, MD PhD202024-12-062026-03-13
Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx IGH Assay
IdentiClone Dx IGH (IC IGH Dx) Assay - B-Cell Lymphoproliferative Disorder
CompletedInvivoscribe, Inc.2502024-01-022024-12-04

Narrower conditions

Waldenstrom Macroglobulinemia (2)  ·  Lymphoma (1)  ·  Lymphoma, B-Cell, Marginal Zone (1)

Broader conditions

Blood Protein Disorders (2)  ·  Cardiovascular Diseases (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Hemorrhagic Disorders (2)  ·  Hemostatic Disorders (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Lymphatic Diseases (2)  ·  Lymphoproliferative Disorders (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Plasma Cell (2)  ·  Paraproteinemias (2)  ·  Vascular Diseases (2)

Interventions

11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (1)

Sponsors

Gottfried von Keudell, MD PhD (1)  ·  Invivoscribe, Inc. (1)  ·  Shayna Sarosiek, MD (1)

Countries

United States (3)  ·  Germany (1)  ·  Japan (1)

Top investigators

Gottfried von Keudell, MD (1)  ·  Shayna Sarosiek, MD (1)